Tsumura & Company Overview
- Founded
- 1893
- Status
- Public
- Employees
- 4,619
- Stock Symbol
- 4540
- Investments
- 1
- Share Price
- $22.86
- (As of Thursday Closing)
Tsumura & Company General Information
Description
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
TKS
Primary Office
- 2-17-11
- Akasaka, Minato-ku
- Tokyo, 107-8521
- Japan
+81 00-0000-0000
Tsumura & Company Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $22.86 | $23.11 | $22.48 - $36.51 | $1.75B | 76.5M | 113K | $2.08 |
Tsumura & Company Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 |
|---|---|---|---|---|
| EV | 2,195,730 | 2,810,818 | 1,881,454 | 2,169,408 |
| Revenue | 1,282,342 | 1,234,266 | 1,133,497 | 1,090,490 |
| EBITDA | 293,560 | 272,380 | 231,743 | 233,727 |
| Net Income | 159,315 | 144,588 | 126,595 | 131,619 |
| Total Assets | 2,941,071 | 2,892,274 | 2,886,843 | 2,591,300 |
| Total Debt | 457,883 | 479,098 | 603,925 | 448,144 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tsumura & Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.
Request a free trialTsumura & Company Patents
Tsumura & Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3438273-A1 | Method for predicting effect of daikenchuto and method for determining dosage of daikenchuto | Pending | 29-Mar-2016 | 00000000 | |
| EP-3438273-A4 | Method for predicting effect of daikenchuto and method for determining dosage of daikenchuto | Pending | 29-Mar-2016 | 00000000 | 0 |
| JP-2017175999-A | Method of predicting the effects of daikenchuto dosage determination method | Pending | 29-Mar-2016 | 00000000 | |
| US-20190119718-A1 | Method for predicting effect of daikenchuto and method for determining dosage of daikenchuto | Pending | 29-Mar-2016 | 00000000 | |
| US-10059976-B2 | Microorganism detection method | Active | 30-Aug-2013 | C12Q1/045 | 0 |
Tsumura & Company Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Terukazu Kato | Chief Executive Officer & Chairman | ||
| Muneki Handa | Chief Financial Officer, Finance & Board Member |
Tsumura & Company Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000000 | Tsumura & Company | Board Member | 000 0000 |
| 00000000 000000 | Tsumura & Company | Board Member | 000 0000 |
| 0000000000 0000000000 | Tsumura & Company | Board Member | 000 0000 |
| 000000 00000 | Tsumura & Company | Chief Financial Officer, Finance & Board Member | 000 0000 |
| 00000000 0000 | Tsumura & Company | Chief Executive Officer & Chairman | 000 0000 |
Tsumura & Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTsumura & Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Tsumura & Company‘s full profile, request access.
Request a free trialTsumura & Company Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00 0 000 | 30-Nov-2017 | 00000 0000 | Drug Discovery | 00000000 |